Scleroderma Renal Crisis and Musculoskeletal Corticosteroid Injections
MSKC injections in established SSc are generally safe with low incidences of SRC and complications. However, it is still prudent to monitor high-risk individuals and recent-onset SSc post-MSKC injection.
Authors
- Frank X. O’Sullivan (ORCID: https://orcid.org/0009-0000-3579-8073)
- James I. Gibb (ORCID: https://orcid.org/0000-0002-8495-712X)
- F Dihowm
- Wilmer L. Sibbitt (ORCID: https://orcid.org/0000-0001-5872-160X)
- Adarsh S. Vangala
- Roderick A. Fields
- Matthew K. McElwee (ORCID: https://orcid.org/0000-0003-1659-6112)
- Eyerusalem B. Akpan
- Sharon E. Nunez
- N. Suzanne Emil (ORCID: https://orcid.org/0000-0002-2241-5464)
- Maheswari Muruganandam (ORCID: https://orcid.org/0000-0001-7916-1031)
- Meredith C. Keller
Institutions
- University of New Mexico (US)
- London Rebuilding Society (GB)
- Kleijnen Systematic Reviews (United Kingdom) (GB)
- Development Fund (NO)
- The Priory Hospital (GB)
Publication Details
- Journal
- JCR Journal of Clinical Rheumatology
- Published
- 2024-11-11
- DOI
- https://doi.org/10.1097/rhu.0000000000002168
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00